Advertisement
Advertisement

COCH

COCH logo

Envoy Medical, Inc. Class A Common Stock

0.63
USD
Sponsored
-0.03
-3.97%
Apr 10, 12:57 UTC -4
Open

COCH Earnings Reports

Positive Surprise Ratio

COCH beat 1 of 8 last estimates.

13%

Next Report

Date of Next Report
Apr 29, 2026
Estimate for Q1 26 (Revenue/ EPS)
$61.20K
/
-$0.14
Implied change from Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q1 25 (Revenue/ EPS)
+33.04%
/
-50.00%

Envoy Medical, Inc. Class A Common Stock earnings per share and revenue

On Mar 23, 2026, COCH reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.32 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 56.10 thousand, with a --% difference. The market reacted with a -9.40% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.14 USD, with revenue projected to reach 61.20 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
logo
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
logo
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
logo
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
logo
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
logo
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
logo
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
logo
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
FAQ
For Q4 2025, Envoy Medical, Inc. Class A Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved down -9.4%, changed from $0.75 before the earnings release to $0.68 the day after.
The next earning report is scheduled for Apr 29, 2026.
Based on 3 analysts, Envoy Medical, Inc. Class A Common Stock is expected to report EPS of -$0.14 and revenue of $61.20K for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement